Atlas Trials

Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy

Clinical trial NCT07436845 · RECRUITING

Trial details

NCT number
NCT07436845
Sponsor
Nanfang Hospital, Southern Medical University
Status
RECRUITING
Study type
OBSERVATIONAL
Hepatocellular Carcinoma (HCC)Emotional DistressHAIC(Hepatic Artery Infusion Chemotherapy)ImmunotherapyTargeted Therapy
Start date
2025-12-01
Primary completion
2028-01-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.